Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

ETF series: S&P Dow Jones Indices

Bell Direct
October 31, 2019

Morning Bell 30 October

Bell Direct
October 30, 2019

Morning Bell 29 October

Bell Direct
October 29, 2019

Morning Bell 28 October

Bell Direct
October 28, 2019

Morning Bell 28 October

Bell Direct
October 28, 2019

Morning Bell 25 October

Bell Direct
October 25, 2019

Morning Bell 24 October

Bell Direct
October 24, 2019

Morning Bell 23 October

Bell Direct
October 23, 2019